View Section: Company Analysis
Virax Biolabs Rating
VR
VRAX stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue
Discover High-rated Companies
View Section: Valuation
VR
Last reporting period 31 Mar, 2022
Updated 24 Dec, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
VR
VRAX stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue